9 insiders reported 106 Form 4 transactions for Axsome Therapeutics, Inc. (AXSM) over the past 18 months (most recent 2026-07-01). Recent activity: TABUTEAU HERRIOT (Chief Executive Officer) Sell 49,666 shares, TABUTEAU HERRIOT (Chief Executive Officer) Buy 49,666 shares, JEFFS ROGER (Director) Sell 286 shares, JEFFS ROGER (Director) Sell 286 shares, Mahony Susan (Director) Buy 1,429 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 49,666 | $11.9M |
| 2026-07-01 | TABUTEAU HERRIOT | Chief Executive Officer | Buy | 49,666 | $245,847 |
| 2026-06-11 | JEFFS ROGER | Director | Sell | 286 | $70,407 |
| 2026-06-11 | JEFFS ROGER | Director | Sell | 286 | $71,248 |
| 2026-06-10 | Mahony Susan | Director | Buy | 1,429 | $0 |
| 2026-06-10 | JEFFS ROGER | Director | Buy | 1,429 | $0 |
| 2026-06-10 | Saad Mark E | Director | Buy | 1,429 | $0 |
| 2026-06-10 | Coleman Mark | Director | Buy | 1,429 | $0 |
| 2026-06-10 | Mahony Susan | Director | Sell | 300 | $71,163 |
| 2026-06-10 | Coleman Mark | Director | Sell | 643 | $160,107 |
| 2026-06-10 | Mahony Susan | Director | Sell | 300 | $73,854 |
| 2026-06-09 | Pizzie Nick | Chief Financial Officer | Buy | 33,000 | $115,500 |
| 2026-06-09 | TABUTEAU HERRIOT | Chief Executive Officer | Buy | 49,670 | $245,866 |
| 2026-06-09 | TABUTEAU HERRIOT | Chief Executive Officer | Sell | 49,670 | $12.0M |
| 2026-06-09 | Pizzie Nick | Chief Financial Officer | Sell | 33,000 | $7.9M |
| 2026-06-02 | Coleman Mark | Director | Sell | 6,000 | $1.4M |
| 2026-06-02 | Coleman Mark | Director | Sell | 6,000 | $1.4M |
| 2026-06-02 | Coleman Mark | Director | Sell | 5,537 | $1.2M |
| 2026-04-23 | Maizel Ari | Chief Commercial Officer | Buy | 7,500 | $530,475 |
| 2026-04-23 | Maizel Ari | Chief Commercial Officer | Sell | 7,500 | $1.4M |
| 2026-02-27 | Jacobson Mark L. | Chief Operating Officer | Buy | 35,378 | $100,827 |
| 2026-02-27 | Jacobson Mark L. | Chief Operating Officer | Sell | 35,378 | $5.7M |
| 2026-02-27 | Coleman Mark | Director | Sell | 25,000 | $4.0M |
| 2026-02-25 | Coleman Mark | Director | Buy | 6,250 | $30,938 |
| 2026-02-23 | Coleman Mark | Director | Buy | 12,485 | $61,801 |
Source: SEC Form 4 filings · as of 2026-07-01